{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T21:56:12Z","timestamp":1776376572441,"version":"3.51.2"},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:00:00Z","timestamp":1772755200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Enabling the unambiguous communication of cancer genetic testing results and the corresponding therapeutic implications of identified genetic variants is of major clinical importance. In this report, we assess the adequacy of the Health Level Seven Fast Healthcare Interoperability Resources (FHIR) Genomics Reporting Implementation Guide, version 3 (also known as \u201cFHIR Genomics\u201d) for the structured communication of semantic objects typically appearing in real-world somatic testing reports.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods<\/jats:title>\n                    <jats:p>The GenomeX project team, part of the CodeX FHIR Accelerator, performed the following assessment: (1) gather a convenience sample of public somatic reports; (2) create a representative somatic report that includes a wide range of observations taken from the sample reports; and (3) structure the representative somatic report using the FHIR Genomics standard.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Attempted encodings were categorized into 1 of the 4 buckets: (1) full encoding possible (eg, DNA variants); (2) full encoding with potential variability (eg, therapeutic implications); (3) partial encoding (eg, genomic study details); and (4) not encoded (ie, FHIR Genomics has no explicit or acceptable semantic target, such as for coarsely granular pertinent negatives). In our sample somatic report, 47 semantic objects were noted, of which 87% had either full encoding or full encoding with potential variability.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>While dynamic real-world requirements, as exemplified by cancer genomics, often arise more rapidly than can be standardized, we conclude that the FHIR Genomics version 3 standard is sufficiently robust for the communication of current actionable somatic testing results.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/jamiaopen\/ooag022","type":"journal-article","created":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T12:42:34Z","timestamp":1772109754000},"source":"Crossref","is-referenced-by-count":0,"title":["Assessment of the adequacy of the Fast Healthcare Interoperability Resources (FHIR) Genomics standard for the representation of somatic testing reports"],"prefix":"10.1093","volume":"9","author":[{"given":"Robert H","family":"Dolin","sequence":"first","affiliation":[{"name":"Elimu Informatics , El Cerrito, CA 94530-2009,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bret S E","family":"Heale","sequence":"additional","affiliation":[{"name":"Humanized Health Consulting , Salt Lake City, UT,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Patterson","sequence":"additional","affiliation":[{"name":"MITRE Corp. , McLean, VA,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin M","family":"Power","sequence":"additional","affiliation":[{"name":"Children\u2019s Mercy , Kansas City, MO,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"May","family":"Terry","sequence":"additional","affiliation":[{"name":"MITRE Corp. , McLean, VA,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Howard","family":"Anton","sequence":"additional","affiliation":[{"name":"Tempus AI , Chicago, IL,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Chen","sequence":"additional","affiliation":[{"name":"Tempus AI , Chicago, IL,","place":["United States"]},{"name":"The Ohio State University , Columbus, OH,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kashmira","family":"Sawant","sequence":"additional","affiliation":[{"name":"Tempus AI , Chicago, IL,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6367-7615","authenticated-orcid":false,"given":"Srikar","family":"Chamala","sequence":"additional","affiliation":[{"name":"Department of Pathology, Keck School of Medicine, University of Southern California , Los Angeles, CA 90033,","place":["United States"]},{"name":"Department of Pathology and Laboratory Medicine, Children\u2019s Hospital Los Angeles , Los Angeles, CA 90027,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2026,3,6]]},"reference":[{"key":"2026041617100201200_ooag022-B1","author":"HL7 FHIR","year":"2025"},{"key":"2026041617100201200_ooag022-B2","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s13073-019-0703-1","article-title":"Molecular profiling for precision cancer therapies","volume":"12","author":"Malone","year":"2020","journal-title":"Genome Med"},{"key":"2026041617100201200_ooag022-B3","doi-asserted-by":"publisher","first-page":"e2323336","DOI":"10.1001\/jamanetworkopen.2023.23336","article-title":"First-line genomic profiling in previously untreated advanced solid tumors for identification of targeted therapy opportunities","volume":"6","author":"Matsubara","year":"2023","journal-title":"JAMA Netw Open"},{"key":"2026041617100201200_ooag022-B4","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.jmoldx.2024.01.005","article-title":"Next-generation sequencing trends among adult patients with select advanced tumor types: a real-world evidence evaluation","volume":"26","author":"Ferreira-Gonzalez","year":"2024","journal-title":"J Mol Diagn"},{"key":"2026041617100201200_ooag022-B5","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.yamp.2019.07.001","article-title":"Genomic data in the electronic health record","volume":"2","author":"Walton","year":"2019","journal-title":"Adv Mol Pathol"},{"key":"2026041617100201200_ooag022-B6","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.3389\/fgene.2019.01059","article-title":"Genomic information for clinicians in the electronic health record: lessons learned from the clinical genome resource project and the electronic medical records and genomics network","volume":"10","author":"Williams","year":"2019","journal-title":"Front Genet"},{"key":"2026041617100201200_ooag022-B7","author":"HL7 Standards Product Brief","year":"2021"},{"key":"2026041617100201200_ooag022-B8","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/j.ajhg.2019.07.018","article-title":"Harmonizing clinical sequencing and interpretation for the eMERGE III network","volume":"105","author":"eMERGE Consortium","year":"2019","journal-title":"Am J Hum Genet"},{"key":"2026041617100201200_ooag022-B9","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12920-018-0360-z","article-title":"Clinical providers\u2019 experiences with returning results from genomic sequencing: an interview study","volume":"11","author":"Wynn","year":"2018","journal-title":"BMC Med Genomics"},{"key":"2026041617100201200_ooag022-B10","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1093\/jamia\/ocv045","article-title":"SMART on FHIR genomics: facilitating standardized clinico-genomic apps","volume":"22","author":"Alterovitz","year":"2015","journal-title":"J Am Med Inform Assoc"},{"key":"2026041617100201200_ooag022-B11","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1093\/jamia\/ocw015","article-title":"SMART precision cancer medicine: a FHIR-based app to provide genomic information at the point of care","volume":"23","author":"Warner","year":"2016","journal-title":"J Am Med Inform Assoc"},{"key":"2026041617100201200_ooag022-B12","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1093\/jamia\/ocv189","article-title":"SMART on FHIR: a standards-based, interoperable apps platform for electronic health records","volume":"23","author":"Mandel","year":"2016","journal-title":"J Am Med Inform Assoc"},{"key":"2026041617100201200_ooag022-B13","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/s41392-024-01823-2","article-title":"Tumor biomarkers for diagnosis, prognosis and targeted therapy","volume":"9","author":"Zhou","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"2026041617100201200_ooag022-B14","year":"2022"},{"key":"2026041617100201200_ooag022-B15","year":"2022"},{"key":"2026041617100201200_ooag022-B16","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1200\/CCI.20.00103","article-title":"Structured data capture for oncology","volume":"5","author":"Goel","year":"2021","journal-title":"JCO Clin Cancer Inform"},{"key":"2026041617100201200_ooag022-B17","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1200\/CCI.20.00059","article-title":"Improving cancer data interoperability: the promise of the minimal common oncology data elements (mCODE) initiative","volume":"4","author":"Osterman","year":"2020","journal-title":"JCO Clin Cancer Inform"},{"key":"2026041617100201200_ooag022-B18","author":"Genomics\u2014CodeX\u2014Confluence","year":"2022"},{"key":"2026041617100201200_ooag022-B19","author":"GenomeX Data Exchange","year":"2025"},{"key":"2026041617100201200_ooag022-B20","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1093\/jamia\/ocad061","article-title":"Creation of a structured molecular genomics report for Germany as a local adaption of HL7\u2019s genomic reporting implementation guide","volume":"30","author":"Stellmach","year":"2023","journal-title":"J Am Med Inform Assoc"},{"key":"2026041617100201200_ooag022-B21","first-page":"683","article-title":"FHIR lab reports: using SMART on FHIR and CDS hooks to increase the clinical utility of pharmacogenomic laboratory test results","volume":"2020","author":"Watkins","year":"2020","journal-title":"AMIA Jt Summits Transl Sci Proc"},{"key":"2026041617100201200_ooag022-B22","doi-asserted-by":"publisher","first-page":"2617","DOI":"10.1093\/jamia\/ocab201","article-title":"Interoperable genetic lab test reports: mapping key data elements to HL7 FHIR specifications and professional reporting guidelines","volume":"28","author":"Khalifa","year":"2021","journal-title":"J Am Med Inform Assoc"},{"key":"2026041617100201200_ooag022-B23","doi-asserted-by":"publisher","first-page":"103795","DOI":"10.1016\/j.jbi.2021.103795","article-title":"Genomic considerations for FHIR\u00ae; eMERGE implementation lessons","volume":"118","author":"Murugan","year":"2021","journal-title":"J Biomed Inform"},{"key":"2026041617100201200_ooag022-B24","author":"Example genetic testing reports (Google Drive)","year":"2024"},{"key":"2026041617100201200_ooag022-B25","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.jmoldx.2016.10.002","article-title":"Standards and guidelines for the interpretation and reporting of sequence variants in cancer","volume":"19","author":"Li","year":"2017","journal-title":"J Mol Diagn"},{"key":"2026041617100201200_ooag022-B26","year":"2024"},{"key":"2026041617100201200_ooag022-B27","year":"2024"},{"key":"2026041617100201200_ooag022-B28","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.humimm.2020.03.005","article-title":"Naming HLA diversity: a review of HLA nomenclature","volume":"82","author":"Hurley","year":"2021","journal-title":"Hum Immunol"},{"key":"2026041617100201200_ooag022-B29","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/s41586-022-04558-8","article-title":"A joint NCBI and EMBL-EBI transcript set for clinical genomics and research","volume":"604","author":"Morales","year":"2022","journal-title":"Nature"}],"container-title":["JAMIA Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jamiaopen\/article\/doi\/10.1093\/jamiaopen\/ooag022\/8508642","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jamiaopen\/article\/doi\/10.1093\/jamiaopen\/ooag022\/8508642","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T21:10:08Z","timestamp":1776373808000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jamiaopen\/article\/doi\/10.1093\/jamiaopen\/ooag022\/8508642"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,6]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,3,6]]}},"URL":"https:\/\/doi.org\/10.1093\/jamiaopen\/ooag022","relation":{},"ISSN":["2574-2531"],"issn-type":[{"value":"2574-2531","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,4]]},"published":{"date-parts":[[2026,3,6]]},"article-number":"ooag022"}}